Skip to main content
Equibles

Franklin Berger

Board Member

Atea Pharmaceuticals, Inc. (AVIR)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Franklin Berger

Franklin Berger is recorded as Board Member at Atea Pharmaceuticals, Inc. (AVIR). Earlier roles on record: Board Member at Kezar Life Sciences, Inc. until May 11, 2026. Kezar Life Sciences, Inc. reported in an 8-K filed May 11, 2026 that Franklin Berger resigned as board of directors of the Company, effective May 11, 2026.

“Pursuant to the terms of the Merger Agreement, at the Effective Time, each of John Fowler, Franklin Berger, Graham Cooper, Elizabeth Garner, M.D., Michael Kauffman, M.D., Ph.D., Micki Klearman, M.D. and Courtney Wallace resigned from the board of directors of the Company.”
Kezar Life Sciences, Inc. Form 8-K, filed May 11, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Kezar Life Sciences, Inc.

Board Member

2016-01-01–2026-05-11

Leadership on record at Atea Pharmaceuticals, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.